Compare BNR & INTT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | BNR | INTT |
|---|---|---|
| Founded | 2014 | 1981 |
| Country | China | United States |
| Employees | N/A | N/A |
| Industry | Medical Specialities | Semiconductors |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 179.7M | 234.0M |
| IPO Year | 2019 | 1997 |
| Metric | BNR | INTT |
|---|---|---|
| Price | $9.02 | $16.79 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $13.50 |
| AVG Volume (30 Days) | 10.1K | ★ 457.5K |
| Earning Date | 06-05-2026 | 05-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.06 |
| Revenue | N/A | ★ $66,801,000.00 |
| Revenue This Year | $111.65 | $15.82 |
| Revenue Next Year | N/A | $9.10 |
| P/E Ratio | ★ N/A | $284.67 |
| Revenue Growth | N/A | ★ 66.06 |
| 52 Week Low | $2.80 | $6.09 |
| 52 Week High | $41.72 | $20.00 |
| Indicator | BNR | INTT |
|---|---|---|
| Relative Strength Index (RSI) | 20.79 | 47.19 |
| Support Level | $7.99 | $7.44 |
| Resistance Level | $9.70 | $19.91 |
| Average True Range (ATR) | 1.17 | 1.52 |
| MACD | -0.72 | -0.21 |
| Stochastic Oscillator | 2.40 | 28.30 |
Burning Rock Biotech Ltd is a cancer diagnostics company. The Group provides pharma research and development services, mainly cancer therapy selection tests services, companion diagnostics development services, and other service agreements with the combination of various customized tests services and analytical validation services, to pharmaceutical companies for developing new drugs for targeted therapies, immunotherapies on various types of cancers, and to hospitals for their studies on cancer diagnosis & treatment. It had three operating segments, including the Central laboratory business, the In-hospital business, & Pharma research & development services. It generates the majority of its revenue from the Central laboratory business. Its products are Pan-HEME, OncoScreen-WES, & others.
inTest Corp is a supplier of test and process technology solutions for use in manufacturing and testing across a wide range of markets, including Semi, Auto/EV, Defense/Aerospace, Industrial, Life Sciences, Safety/Security, and Other. The Company has three operating segments, which are also its reportable segments and reporting units: Electronic Test, which generates the majority of its revenue and includes semiconductor test equipment, flying probe, and in-circuit testers; Environmental Technologies, which includes thermal test, process, and storage products; and Process Technologies, which includes induction heating and video imaging products. The Company generates the maximum revenue from the U.S.